Researchers from the Columbia University Department of Neurology discovered a genetic variant that may reduce the odds of developing Alzheimer’s disease by up to 70%.
Sharon Sanz Simon, PhD, Associate Research Scientist in the Gertrude H. Sergievsky Center, discusses the Alzheimer's disease and related dementia in the Brazilian community living in the U.S.
Martin Picard, PhD, Associate Professor of Behavioral Medicine in Psychiatry, Neurology, and the Robert N. Butler Columbia Aging Center is the first to receive the new Baszucki Prize in Science.
Neil A. Shneider, MD, PhD, Claire Tow Associate Professor of Motor Neuron Disorders, is the principal investigator on the grant that will help develop drugs for an underserved portion of ALS patients.
Andrew B. Lassman, MD, Professor of Neurology & Associate Dean of Clinical Trials at Columbia University, talks about the importance of enrolling a diverse population of subjects in clinical trials
Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, and colleagues led a study that found eye drop treatment alternative to Retinal vein occlusion (RVO) disease
Adam M. Brickman, PhD, Professor of Neuropsychology, and Scott A. Small, MD, Boris and Rose Katz Professor of Neurology, discuss their study that examined health benefits of flavanol-rich diet
Scott Small, MD, Boris & Rose Katz Professor of Neurology and Director & Alzheimer's Disease Research Center at CUIMC talks about the study that examined flavanols levels and memory loss
Adam M. Brickman, PhD, Professor of Neuropsychology, and colleagues conducted a large study that found that taking a daily multivitamin supplement can slow age-related memory decline
Adam M. Brickman, PhD, Professor of Neuropsychology, led a study that tried to determine what effect taking a daily vitamin can have on memory function
Jason B. Carmel, MD, PhD, Weinberg Family Associate Professor of Neurology, talks about a family tragedy that inspired him to focus his work on helping people with a spinal cord injury
Stephanie Cosentino, PhD, Associate Professor of Neuropsychology, and colleagues are working on developing screening tools to detect subjective cognitive decline and more advanced forms of memory loss
Neil Shneider, MD, PhD, Claire Tow Associate Professor of Neurology, talks about the new approved tofersen (Qalsody), the first drug developed for patients with a rare form of ALS
A new study done by Dr. Jennifer Manly, professor of neuropsychology, and colleagues, found that the quality of the high school you attend may have an impact on cognition later in life